Advertisement
Screener

JASPER THERAPEUTICS, INC. (JSPR) Cash Flow Breakdown

JASPER THERAPEUTICS, INC. Cash Flow Breakdown

Cash flow breakdown shows where JASPER THERAPEUTICS, INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $77.16M went out.
  • Fiscal year ended 2025-12-31: from investing, $5.00K came in.
  • Fiscal year ended 2025-12-31: from financing, $34.21M came in.
  • Fiscal year ended 2025-12-31: change in cash, $42.95M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingCommercial paperStaff share taxNew shares soldNot split outChange in cash
2025-12-31-$77.16M$5.00K$6.45M$27.76M*-$42.95M
2024-12-31-$62.60M-$532.00K$47.20M$689.00K*-$15.25M
2023-12-31-$52.07M-$267.00K-$960.00K$101.48M$48.64M
2022-12-31-$45.86M-$576.00K$1.07M*$27.00K-$46.38M
2021-12-31-$33.68M-$2.43M$235.00K$100.73M*$64.86M
2020-12-31-$18.27M$198.34K$345.00K$53.00K$10.89M*-$442.64K

Each quarter (3 month)

Quarter endRunning the businessFrom investingCommercial paperStaff share taxNew shares soldNot split outChange in cash
2026-06-30-$6.92M*
2026-03-31-$14.55M-$14.55M
2025-12-31-$21.87M*$0.00*$0.00*
2025-09-30-$17.00M*$0.00*$514.00K*$27.87M*
2025-06-30-$15.45M*$1.00K*
2025-03-31-$22.84M$4.00K-$22.84M
2024-12-31-$21.13M*-$76.00K*$30.00K*
2024-09-30-$14.05M*-$274.00K*$0.00*
2024-06-30-$11.68M*-$157.00K*$0.00*
2024-03-31-$15.74M-$25.00K$47.20M$31.59M
2023-12-31-$16.48M*-$230.00K*-$299.00K*$0.00*
2023-09-30-$11.98M*$0.00*$0.00*$0.00*
2023-06-30-$13.27M*-$11.00K*$0.00*
2023-03-31-$10.34M-$26.00K$101.48M$91.15M
2022-12-31-$12.65M*-$82.00K*$0.00*$0.00*
2022-09-30-$9.64M*-$222.00K*$0.00*$1.00K*
2022-06-30-$9.36M*-$243.00K*-$57.00K*$13.00K*
2022-03-31-$14.21M-$29.00K$1.13M*$13.00K-$14.23M
2021-12-31-$14.58M*-$711.00K*$33.00K*-$942.00K*
2021-09-30-$7.11M*-$470.00K*$132.00K*$91.59M*
2021-06-30-$5.79M*-$287.00K*$68.00K*-$668.00K*
2021-03-31-$6.20M-$960.00K$2.00K$10.75M*-$179.51K
2020-12-31-$5.39M*$17.95K*$10.80M*
2020-09-30-$12.47M*$72.18K*
2020-06-30-$173.85K*$30.90K*
2020-03-31-$232.87K$77.31K-$155.56K

Similar stocks

Stock NameCountryMarket CapPE Ratio
Estrella Immunopharma, Inc. (ESLA)United States$0.020B
BioCardia, Inc. (BCDA)United States$0.016B
DYADIC INTERNATIONAL INC (DYAI)United States$0.016B
Passage BIO, Inc. (PASG)United States$0.015B-0.43
Pluri Inc. (PLUR)$0.014B
INTENSITY THERAPEUTICS, INC. (INTS)United States$0.013B-1.08
BRAINSTORM CELL THERAPEUTICS INC. (BCLI)United States$0.013B-1.05
IN8BIO, INC. (INAB)United States$0.012B-0.76
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70
CEL SCI CORP (CVM)United States$0.030B-0.81